WELL Health Technologies (TSE:WELL) Price Target Raised to C$8.25

WELL Health Technologies (TSE:WELL) had its target price raised by Stifel Nicolaus from C$8.00 to C$8.25 in a research report issued to clients and investors on Wednesday,BayStreet.CA reports. The brokerage presently has a “buy” rating on the stock. Stifel Nicolaus’ price target suggests a potential upside of 70.10% from the company’s current price.

Separately, Scotiabank cut their price objective on WELL Health Technologies from C$7.00 to C$6.50 and set an “outperform” rating on the stock in a research note on Wednesday, February 4th. Three equities research analysts have rated the stock with a Buy rating, According to MarketBeat, the stock presently has an average rating of “Buy” and an average target price of C$6.92.

WELL Health Technologies Trading Down 0.6%

Shares of WELL Health Technologies stock traded down C$0.03 during midday trading on Wednesday, reaching C$4.85. The company had a trading volume of 1,698,436 shares, compared to its average volume of 1,505,664. The stock has a fifty day moving average price of C$4.06 and a 200 day moving average price of C$4.05. The company has a debt-to-equity ratio of 91.15, a current ratio of 0.83 and a quick ratio of 1.02. The firm has a market cap of C$1.24 billion, a PE ratio of 44.09, a P/E/G ratio of -1.93 and a beta of 0.87. WELL Health Technologies has a fifty-two week low of C$3.58 and a fifty-two week high of C$6.08.

WELL Health Technologies (TSE:WELL) last posted its quarterly earnings data on Thursday, May 7th. The company reported C$0.06 EPS for the quarter. The company had revenue of C$368.26 million for the quarter. WELL Health Technologies had a return on equity of 3.15% and a net margin of 1.82%. On average, equities analysts anticipate that WELL Health Technologies will post 0.3000698 earnings per share for the current year.

WELL Health Technologies Company Profile

WELL Health Technologies Corp is the owner and operator of a portfolio of Primary Hclinics delivering healthcare-related services It operates through below segments: clinical operations and allied health, Electronic medical record (EMR), Billing and revenue cycle management solutions, Digital apps, Cybersecurity, CRH, MyHealth, and corporate/shared services. Its segments are grouped in three divisions; Omni-channel Patient Services – Primary includes clinical operations and allied health. Omni-channel Patient Services – Specialized comprises CRH and MyHealth under two segments.